Patents for A61P 19 - Drugs for skeletal disorders (81,981)
07/2011
07/07/2011US20110166107 Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof
07/07/2011US20110166104 Boron-containing small molecules
07/07/2011US20110166103 Boron-containing small molecules
07/07/2011US20110166102 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
07/07/2011US20110166093 Use of adenosine receptor agonists in therapy
07/07/2011US20110166072 Polypeptides Selective for avB3 Integrin, Including Pegylated Polypeptides, And Pharmaceutical Uses Thereof
07/07/2011US20110165251 Liquid dosage compositions of stable nanoparticulate active agents
07/07/2011US20110165245 Compositions and methods for distraction osteogenesis
07/07/2011US20110165218 Therapeutic Bone Growth and Regeneration
07/07/2011US20110165215 Cohesive osteogenic putty and materials therefor
07/07/2011US20110165211 Carbon dioxide external preparation, and material for formation of carbon dioxide external preparation
07/07/2011US20110165200 Novel hydrogels and uses thereof
07/07/2011US20110165199 Composition and Process for Bone Growth and Repair
07/07/2011US20110165166 Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
07/07/2011US20110165156 Antibodies against human csf-1r and uses thereof
07/07/2011US20110165144 Methods for treating rheumatoid arthritis
07/07/2011US20110165132 Heparan Sulphate Which Binds BMP2
07/07/2011US20110165122 Method for targeted and sustained antiviral therapy
07/07/2011US20110165116 Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation
07/07/2011US20110165096 Ficus Extracts Having Angiogenesis Ihibiting Activity And Methods Of Isolating And using The Same
07/07/2011US20110165066 Interleukin-13 binding proteins
07/07/2011US20110165063 Il-1 binding proteins
07/06/2011EP2341143A1 OX2 receptor homolog
07/06/2011EP2341080A1 Humanized immunoglobulins and their production and use
07/06/2011EP2341068A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
07/06/2011EP2341049A1 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as PTPASE 1B inhibitors
07/06/2011EP2341048A1 Thiazolium salt compound and the use of treating the protein aging disease
07/06/2011EP2340849A1 Anti-NGF antibodies for the treatment of various disorders
07/06/2011EP2340841A1 Osteogenesis promoter comprising [4-(methylthio)phenylthio]methanebisphosphonic acid or pharmaceutically acceptable salt thereof as active ingredient
07/06/2011EP2340243A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
07/06/2011EP2340039A1 Use of il-20 antagonists for treating rheumatoid arthritis and osteoporosis
07/06/2011EP1763362B1 Use of op-1 for treating cartilage defects
07/06/2011EP1537146B9 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections
07/06/2011EP1317283B1 Tweak receptor agonists as anti-angiogenic agents
07/06/2011EP1228076B1 A substantially cell membrane impermeable compound and use thereof
07/06/2011EP1173484B1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
07/06/2011CN1903220B Health-care food with function of improving skeletal density and its prepn. method
07/06/2011CN102119174A Compositions and methods of use for therapeutic antibodies
07/06/2011CN102119160A Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
07/06/2011CN102119138A Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid
07/06/2011CN102115721A Lactobacillus isolated strains with anti-inflammatory activity and use thereof
07/06/2011CN102114271A Multi-medicament loaded calcium phosphate cement powder
07/06/2011CN102114245A Special solvent for daidzein pre-emulsified injection and preparation method and purpose thereof
07/06/2011CN102114225A Traditional Chinese medicine for treating gout of diabetes patient
07/06/2011CN102114220A Quality control method for Chinese medicinal preparation for treating traumatic injuries and rheumatoid sacrodynia
07/06/2011CN102114215A Traditional Chinese medicine composition for treating gout and hyperuricemia and preparation method thereof
07/06/2011CN102114212A Traditional Chinese medicine for treating diabetic gout
07/06/2011CN102114204A Traditional Chinese medicine formula for treating gout
07/06/2011CN102114165A Plaster for treating pain of cervical and lumbar vertebrae and preparation method thereof
07/06/2011CN102114146A Oral Chinese medicinal liquor for treating wind chill leg pain
07/06/2011CN102114091A Externally-applied paste for treating fracture
07/06/2011CN102114088A Chinese medicine preparation for treating bone fracture
07/06/2011CN102114078A Chinese medicine extract for promoting fracture healing and preparation method and application thereof
07/06/2011CN102114070A Compound traditional Chinese medicine for treating osteoporosis and preparation method thereof
07/06/2011CN102114025A Pharmaceutical composition for treating osteoporosis
07/06/2011CN102113996A Oral formulations containing protein or peptide, and preparation method and application thereof
07/06/2011CN102113984A Composite with function of reducing weight of abdomen
07/06/2011CN102113932A Multifunctional saline-alkaline heat transfer treatment baking bed and preparation method thereof
07/06/2011CN101837080B Topical ointment externally used for treating cervical spondylosis
07/06/2011CN101708166B Cefpodoxime proxetil submicron emulsion solid preparation and novel application thereof
07/06/2011CN101278953B Externally-applied medicine for curing hydrarthrosis of knee and method of processing the same
07/06/2011CN101119986B Optically active tetrahydronaphthalene derivative
07/06/2011CN101052397B 2-sulfanyl-benzimidazol-1-yl-acetic acid derivatives as crth2 antagonists
07/06/2011CN101048408B Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
07/05/2011US7973170 N3 alkylated benzimidazole derivatives as MEK inhibitors
07/05/2011US7973160 Nitrogen-containing aromatic derivatives
07/05/2011US7973037 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders
07/05/2011US7973031 Leukemia therapy ;myelodyspastic syndrome
07/05/2011US7973024 24-sulfoximine vitamin D3 compounds
07/05/2011US7973010 Full length polynucleotide coding chicken type II collagen and the use of it
07/05/2011US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse
07/05/2011US7972630 Injectable bone mineral substitute material
07/05/2011CA2531484C Novel bioisosteres of actinonin
07/05/2011CA2486728C Novel physiologically active substances useful for suppressing vegf production
07/05/2011CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
07/05/2011CA2475867C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
06/2011
06/30/2011WO2011079103A1 Spiropiperidine benzylamines as beta-tryptase inhibitors
06/30/2011WO2011079076A1 Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors
06/30/2011WO2011079051A1 Fused heteroaromatic pyrrolidinones as syk inhibitors
06/30/2011WO2011078799A1 Treatment of bone fracture
06/30/2011WO2011078795A1 Bridged morpholino substituted purines
06/30/2011WO2011078413A1 Seven-membered ring compound and pharmaceutical use therefor
06/30/2011WO2011078221A1 Imidazopyridazine compounds
06/30/2011WO2011077159A1 Treatment of osteoporosis
06/30/2011WO2011076880A1 Methods and use related to humanin and humanin-like peptides
06/30/2011WO2011076596A1 A combination for the treatment of osteoarthritis
06/30/2011WO2011011706A3 Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents
06/30/2011US20110162095 TNFSF Single Chain Molecules
06/30/2011US20110160642 Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases
06/30/2011US20110160298 Pharmaceutical composition for prevention and/or treatment of bone loss
06/30/2011US20110160296 Preparation of 6-oxa-8alpha-steroid estrogen analogues - a new group of unnatural estrogens and their use in medicine
06/30/2011US20110160291 Oligonucleotide Compositions and Their Use to Induce Apoptosis
06/30/2011US20110160273 Co-crystals of duloxetine and cox-inhibitors for the treatment of pain
06/30/2011US20110160270 Deuterium-enriched sdx-101
06/30/2011US20110160256 Inhibitors of akt activity
06/30/2011US20110160255 Inhibitors of akt activity
06/30/2011US20110160235 Triazolyl tropane derivatives
06/30/2011US20110160234 Tricyclic Compounds as Modulators of TNF-alpha Synthesis and as PDE4 Inhibitors
06/30/2011US20110160232 Certain chemical entities and therapeutic uses thereof
06/30/2011US20110160229 Ahcy hydrolase inhibitors for treatment of hyper homocysteinemia